In the first half of the year, 68 pharmaceutical executives with revenues of more than 100 million yuan left.

"
Pharmaceutical Network Industry Dynamic" In the first half of this year, the pharmaceutical industry personnel changes frequentlyRecently, the industry combed found that in 2019 revenue of more than 100 million yuan of listed pharmaceutical companies, about 68 enterprises have adjusted their senior managementspecific point of view, in the first half of the year Fosun Pharma, Northeast Pharmaceuticals, Jiuzhitang, Dongcheng Pharmaceuticals, Jiangsu Wuzhong, Lisheng Pharmaceutical snare the number of senior executives leaving 4 people and aboveAmong them, the first half of Jiuzhitang six executives "out." China Pharmaceuticals, Ruikang Pharmaceuticals, Fosun Pharma, Renfu Pharmaceuticals, Hyundai Pharmaceuticals, Harsun Pharmaceuticals, Tongjitang, Haizheng Pharmaceuticals, Zhifei Bio, the 10 pharmaceutical companies with revenues of more than 10 billion yuan in 2019, and in the first half of this year alone, about 17 executives have applied to resign or leaveaccording to incomplete statistics, the reasons for the departure of pharmaceutical executives mainly include work reasons, personal reasons, term expiration, job division adjustment, among which mainly for personal reasonsIn fact, there are personal reasons for any departure, but the underlying reason behind it is worth thinking about, especially since 2020 is a very special timewhat is the reason why so many pharmaceutical executives have chosen to leave in the first half of the year? Industry analysts believe that this is the inevitable result of short-term reality and long-term policy influenceIn fact, since the first half of the year, many pharmaceutical companies have been affected by the epidemicAccording to statistics, more than 50% of A-share pharmaceutical companies in the first quarter of this year's operating income and net profit fell, 53 pharmaceutical companies net profit loss, compared with 16 in the same period last yearAs of June 5, a total of 39 pharmaceutical companies reported first-half results, less than half of the pharmaceutical companies are happyin the special period, drug companies under the line of activity is limited, sales performance is limited to varying degrees, decline, which makes pharmaceutical companies have to start to adjust business patterns or directchange organizational structureIn the process, some executives are affected and can only choose to leaveof course, the above reasons are only special reasons for the special period, in the long run, the 4 plus 7 band procurement, two-vote system, tender price reduction, medical insurance control fees and consistency evaluation and other national new round of medical reform policy, so that the pharmaceutical industry long-term pressureUnder the challenge, pharmaceutical companies to adjust management, change personnel system, optimize the business team, pharmaceutical personnel to find new career development opportunities are high probability events before, Renfu Pharmaceuticals' new chairman Li Jie has told the media that the change soriented in corporate personnel is mainly in line with the company's strategic adjustment In addition, it also mentions that "nuclear focus" will become the main development strategy of the future of the well-known medicine In this regard, the industry agrees that the personnel adjustment of pharmaceutical enterprises is the inevitable result of drastic changes in the pattern of the pharmaceutical industry and the reshaping of the pharmaceutical market pattern and in this trend, the future in addition to senior executives, the general turnover of ordinary employees will be the norm But for the pharmaceutical people, can be based on the industry, rely on only strength No matter how the environment changes, what medical people can do is to strive to strengthen their strength, through continuous learning to improve their business ability In this way, even in the face of any industry wind and rain, medical perpeople can have more and better development opportunities.